Aier Eye Hospital Group to Acquire Stake in Southeast Asian Eye Care Leader ISEC Healthcare Ltd.

Original Title:Aier Eye HospitalProposed Acquisition of Equity Stake in ISEC Healthcare, an Ophthalmic Medical Group Source: Shanghai Securities News

Shanghai Securities News China Securities Network (Reporter Luo Min): Aier Eye Hospital announced that the company plans to acquire a 35% stake in the Singapore-listed company ISEC Healthcare Ltd. (“ISEC”) through its wholly-owned subsidiary, Singapore Aier. The acquisition price is S$0.36 per share, with the consideration for the 35% stake amounting to S$67,075,916.76 in cash. According to the “Share Transfer Agreement” signed between Singapore Aier and seven shareholders of ISEC who collectively hold 58.78% of the company’s equity, these selling shareholders will transfer a total of 35% of their shares to Singapore Aier within five working days after receiving notification that the prerequisites have been met. Upon completion of the 35% equity transfer, Singapore Aier will launch a public tender offer in the open market at a price of S$0.36 per share. Through this acquisition, Singapore Aier’s minimum shareholding will be 35%. If all shareholders in the open market accept the tender offer, Singapore Aier’s maximum shareholding will reach 78.22%. Based on the tender offer price of S$0.36 per share, the total maximum consideration for this acquisition will be approximately S$150 million. The company stated that acquiring ISEC, a leading ophthalmic medical group in Southeast Asia, allows for rapid entry into the region’s most developed markets, such as Singapore and Malaysia, marking a significant step in the company’s internationalization strategy.